Literature DB >> 16425368

DNA end binding activity and Ku70/80 heterodimer expression in human colorectal tumor.

Paola Mazzarelli1, Paola Parrella, Davide Seripa, Emanuela Signori, Giuseppe Perrone, Carla Rabitti, Domenico Borzomati, Armando Gabbrielli, Maria Giovanna Matera, Carolina Gravina, Marco Caricato, Maria Luana Poeta, Monica Rinaldi, Sergio Valeri, Roberto Coppola, Vito Michele Fazio.   

Abstract

AIM: To determine the DNA binding activity and protein levels of the Ku70/80 heterodimer, the functional mediator of the NHEJ activity, in human colorectal carcinogenesis.
METHODS: The Ku70/80 DNA-binding activity was determined by electrophoretic mobility shift assays in 20 colon adenoma and 15 colorectal cancer samples as well as matched normal colonic tissues. Nuclear and cytoplasmic protein expression was determined by immunohistochemistry and Western blot analysis.
RESULTS: A statistically significant difference was found in both adenomas and carcinomas as compared to matched normal colonic mucosa (P<0.00). However, changes in binding activity were not homogenous with approximately 50% of the tumors showing a clear increase in the binding activity, 30% displaying a modest increase and 15% showing a decrease of the activity. Tumors, with increased DNA-binding activity, also showed a statistically significant increase in Ku70 and Ku86 nuclear expression, as determined by Western blot and immunohistochemical analyses (P<0.001). Cytoplasmic protein expression was found in pathological samples, but not in normal tissues either from tumor patients or from healthy subjects.
CONCLUSION: Overall, our DNA-binding activity and protein level are consistent with a substantial activation of the NHEJ pathway in colorectal tumors. Since the NHEJ is an error prone mechanism, its abnormal activation can result in chromosomal instability and ultimately lead to tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16425368      PMCID: PMC4355768          DOI: 10.3748/wjg.v11.i42.6694

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  28 in total

Review 1.  Chromosomal stability and the DNA double-stranded break connection.

Authors:  D C van Gent; J H Hoeijmakers; R Kanaar
Journal:  Nat Rev Genet       Date:  2001-03       Impact factor: 53.242

Review 2.  Mechanism and regulation of human non-homologous DNA end-joining.

Authors:  Michael R Lieber; Yunmei Ma; Ulrich Pannicke; Klaus Schwarz
Journal:  Nat Rev Mol Cell Biol       Date:  2003-09       Impact factor: 94.444

Review 3.  A mutator phenotype in cancer.

Authors:  L A Loeb
Journal:  Cancer Res       Date:  2001-04-15       Impact factor: 12.701

4.  Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses.

Authors:  Kai Rothkamm; Markus Löbrich
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-04       Impact factor: 11.205

5.  Immunoreactivity to monoclonal antibody, Hep Par 1, in human hepatocellular carcinomas according to histopathological grade and histological pattern.

Authors:  I Kumagai; T Masuda; S -i. Sato; K Ishikawa
Journal:  Hepatol Res       Date:  2001-07       Impact factor: 4.288

6.  Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development.

Authors:  Y Gao; D O Ferguson; W Xie; J P Manis; J Sekiguchi; K M Frank; J Chaudhuri; J Horner; R A DePinho; F W Alt
Journal:  Nature       Date:  2000-04-20       Impact factor: 49.962

Review 7.  Sensing and repairing DNA double-strand breaks.

Authors:  Stephen P Jackson
Journal:  Carcinogenesis       Date:  2002-05       Impact factor: 4.944

8.  DNA repair protein Ku80 suppresses chromosomal aberrations and malignant transformation.

Authors:  M J Difilippantonio; J Zhu; H T Chen; E Meffre; M C Nussenzweig; E E Max; T Ried; A Nussenzweig
Journal:  Nature       Date:  2000-03-30       Impact factor: 49.962

9.  Prediction of tumor radiosensitivity in rectal carcinoma based on p53 and Ku70 expression.

Authors:  Y Komuro; T Watanabe; Y Hosoi; Y Matsumoto; K Nakagawa; S Saito; S Ishihara; S Kazama; N Tsuno; J Kitayama; N Suzuki; G Tsurita; T Muto; H Nagawa
Journal:  J Exp Clin Cancer Res       Date:  2003-06

10.  The expression pattern of Ku correlates with tumor radiosensitivity and disease free survival in patients with rectal carcinoma.

Authors:  Yasuhiro Komuro; Toshiaki Watanabe; Yoshio Hosoi; Yoshihisa Matsumoto; Keiichi Nakagawa; Nelson Tsuno; Shinsuke Kazama; Joji Kitayama; Norio Suzuki; Hirokazu Nagawa
Journal:  Cancer       Date:  2002-09-15       Impact factor: 6.860

View more
  12 in total

1.  Rab5C enhances resistance to ionizing radiation in rectal cancer.

Authors:  Antuani Rafael Baptistella; Michele Christine Landemberger; Marcos Vinicios Salles Dias; Fernanda Salgueiredo Giudice; Bruna Roz Rodrigues; Petrus Paulo Combas Eufrazio da Silva; Edson Kuatelela Cassinela; Tonielli Cristina Lacerda; Fabio Albuquerque Marchi; Adriana Franco Paes Leme; Maria Dirlei Begnami; Samuel Aguiar; Vilma Regina Martins
Journal:  J Mol Med (Berl)       Date:  2019-04-09       Impact factor: 4.599

Review 2.  The Ku complex: recent advances and emerging roles outside of non-homologous end-joining.

Authors:  Sanna Abbasi; Gursimran Parmar; Rachel D Kelly; Nileeka Balasuriya; Caroline Schild-Poulter
Journal:  Cell Mol Life Sci       Date:  2021-04-15       Impact factor: 9.261

3.  NHJ-1 Is Required for Canonical Nonhomologous End Joining in Caenorhabditis elegans.

Authors:  Aleksandar Vujin; Steven J Jones; Monique Zetka
Journal:  Genetics       Date:  2020-05-26       Impact factor: 4.562

Review 4.  The Role of the Core Non-Homologous End Joining Factors in Carcinogenesis and Cancer.

Authors:  Brock J Sishc; Anthony J Davis
Journal:  Cancers (Basel)       Date:  2017-07-06       Impact factor: 6.639

5.  Induction Of XLF And 53BP1 Expression Is Associated With Temozolomide Resistance In Glioblastoma Cells.

Authors:  Tongxia Zhang; Jie Chai; Lingyi Chi
Journal:  Onco Targets Ther       Date:  2019-11-25       Impact factor: 4.147

Review 6.  Druggable binding sites in the multicomponent assemblies that characterise DNA double-strand-break repair through non-homologous end joining.

Authors:  Antonia Kefala Stavridi; Robert Appleby; Shikang Liang; Tom L Blundell; Amanda K Chaplin
Journal:  Essays Biochem       Date:  2020-10-26       Impact factor: 8.000

7.  Ku protein levels, localization and association to replication origins in different stages of breast tumor progression.

Authors:  Khalil Abdelbaqi; Domenic Di Paola; Emmanouil Rampakakis; Maria Zannis-Hadjopoulos
Journal:  J Cancer       Date:  2013-05-26       Impact factor: 4.207

8.  Selective Targeting to Glioma with Nucleic Acid Aptamers.

Authors:  Shraddha Aptekar; Mohit Arora; Clare Louise Lawrence; Robert William Lea; Katherine Ashton; Tim Dawson; Jane Elizabeth Alder; Lisa Shaw
Journal:  PLoS One       Date:  2015-08-07       Impact factor: 3.240

9.  The different biological effects of single, fractionated and continuous low dose rate irradiation on CL187 colorectal cancer cells.

Authors:  Hao Wang; Jinna Li; Ang Qu; Jingjia Liu; Yong Zhao; Junjie Wang
Journal:  Radiat Oncol       Date:  2013-08-09       Impact factor: 3.481

10.  Differences of Variable Number Tandem Repeats in XRCC5 Promoter Are Associated with Increased or Decreased Risk of Breast Cancer in BRCA Gene Mutation Carriers.

Authors:  Jian Cui; Jiangtao Luo; Yeong C Kim; Carrie Snyder; Dina Becirovic; Bradley Downs; Henry Lynch; San Ming Wang
Journal:  Front Oncol       Date:  2016-04-13       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.